HVO vs. FARN, VRP, ARIX, BVXP, CIR, 4BB, AVCT, TILS, VSN, and OBI
Should you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Bioventix (BVXP), Circassia Group (CIR), 4basebio (4BB), Avacta Group (AVCT), Tiziana Life Sciences (TILS), Verseon (VSN), and Ondine Biomedical (OBI). These companies are all part of the "biotechnology" industry.
hVIVO vs. Its Competitors
hVIVO (LON:HVO) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.
34.9% of hVIVO shares are held by institutional investors. Comparatively, 10.7% of Faron Pharmaceuticals Oy shares are held by institutional investors. 14.0% of hVIVO shares are held by insiders. Comparatively, 31.8% of Faron Pharmaceuticals Oy shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
hVIVO has a net margin of 25.96% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. hVIVO's return on equity of 47.93% beat Faron Pharmaceuticals Oy's return on equity.
hVIVO has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks.
hVIVO has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500.
In the previous week, hVIVO had 1 more articles in the media than Faron Pharmaceuticals Oy. MarketBeat recorded 1 mentions for hVIVO and 0 mentions for Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy's average media sentiment score of 1.16 beat hVIVO's score of 0.59 indicating that Faron Pharmaceuticals Oy is being referred to more favorably in the news media.
Summary
hVIVO beats Faron Pharmaceuticals Oy on 12 of the 14 factors compared between the two stocks.
Get hVIVO News Delivered to You Automatically
Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:HVO) was last updated on 7/18/2025 by MarketBeat.com Staff
Free HVO Stock Alerts